Skip to main content
. 2022 Nov 2;13:1024197. doi: 10.3389/fpsyg.2022.1024197

Table 2.

ERPs amplitude in study phase (M ± SD).

Type P1(uV) N170(uV) P2(uV) N300(uV)
FN group Control group FN group Control group FN group Control group FN group Control group
High 6.64 ± 0.75 8.16 ± 1.16 −10.40 ± 1.11 −12.604 ± 1.03 4.50 ± 0.99 1.13 ± 1.02 −8.83 ± 0.63 −5.90 ± 0.75
Middle 6.31 ± 0.80 6.66 ± 1.19 −10.20 ± 1.01 −12.511 ± 0.97 3.82 ± 0.72 0.64 ± 0.87 −7.52 ± 0.62 −4.37 ± 1.00
Low 7.83 ± 0.80 6.64 ± 1.19 −12.08 ± 1.00 −10.571 ± 1.04 3.53 ± 0.95 0.03 ± 0.96 −6.91 ± 0.79 −4.14 ± 0.95
Total 3.98 ± 0.87 0.56 ± 0.94 −7.75 ± 0.66 −4.81 ± 0.87